Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic Treatments

25 Apr 2021

Abstract excerpt

Clear cell renal cell carcinoma (ccRCC) is curable when diagnosed at an early stage, but when disease is non-confined it is the urologic cancer with worst prognosis. Antiangiogenic treatment and immune checkpoint inhibition therapy constitute a very promising combined therapy for advanced and metastatic disease. Many exploratory studies have identified epigenetic markers based on DNA methylation, histone...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Renal and related cancers
Share to Renal cell carcinoma treatment

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33922974
DOI: 10.3390/cancers13092071

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Role of Epigenetics in the Progression of Clear Cell Renal Cell Carcinoma and the Basis for Future Epigenetic TreatmentsPMID 33922974Read ↗

Epigenomics of clear cell renal cell carcinoma: mechanisms and potential use in molecular pathology.Semantic proximity Read ↗

An Overview of Epigenetics in Clear Cell Renal Cell CarcinomaSemantic proximity Read ↗

The Epigenetics of Renal Cell Tumors: from Biology to BiomarkersSemantic proximity Read ↗

Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.Semantic proximity Read ↗

DNA methylation associates with survival in non-metastatic clear cell renal cell carcinomaSemantic proximity Read ↗

Epigenetics in renal cell cancer: mechanisms and clinical applications.Semantic proximity Read ↗

Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and ProcessesSemantic proximity Read ↗

Novel Molecular Subtypes and Related Score Based on Histone Acetylation Modification in Renal Clear Cell CarcinomaSemantic proximity Read ↗

Genomic Profiling and Molecular Characterization of Clear Cell Renal Cell Carcinoma.Semantic proximity Read ↗

Epigenetic regulation in RCC: opportunities for therapeutic intervention?Semantic proximity Read ↗

A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer PatientsSemantic proximity Read ↗

Epigenetic Biomarkers of Renal Cell Carcinoma for Liquid Biopsy TestsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.